Nonredundant Functions for Tumor Protein D52-Like Proteins Support Specific Targeting of TPD52

Purpose:Tumor protein D52 (TPD52 or D52) is frequently overexpressed in breast and other cancers and present at increased gene copy number. It is, however, unclear whether D52 amplification and overexpression target specific functional properties of the encoded protein. Experimental Design: The expression of D52-like genes and MAL2 was compared in breast tissues using quantitative reverse transcription-PCR. The functions of human D52 and D53 genes were then compared by stable expression in BALB/c 3T3 fibroblasts and transient gene knockdown in breast carcinoma cell lines. In situ D52 and MAL2 protein expression was analyzed in breast tissue samples using tissue microarray sections. Results: The D52 (8q21.13), D54 (20q13.33), and MAL2 (8q24.12) genes were significantly overexpressed in breast cancer tissue (n = 95) relative to normal breast (n = 7; P ≤ 0.005) unlike the D53 gene (6q22.31; P = 0.884). Subsequently, D52-expressing but not D53-expressing 3T3 cell lines showed increased proliferation and anchorage-independent growth capacity, and reduced D52 but not D53 expression in SK-BR-3 cells significantly increased apoptosis. High D52 but not MAL2 expression was significantly associated with reduced overall survival in breast carcinoma patients (log-rank test, P < 0.001; n = 357) and was an independent predictor of survival (hazard ratio, 2.274; 95% confidence interval, 1.228-4.210; P = 0.009; n = 328). Conclusion: D52 overexpression in cancer reflects specific targeting and may contribute to a more proliferative, aggressive tumor phenotype in breast cancer.

[1]  Howard Y. Chang,et al.  Genetic regulators of large-scale transcriptional signatures in cancer , 2006, Nature Genetics.

[2]  S. Knuutila,et al.  DNA copy number amplification profiling of human neoplasms , 2006, Oncogene.

[3]  J. Benítez,et al.  The Accumulation of Specific Amplifications Characterizes Two Different Genomic Pathways of Evolution of Familial Breast Tumors , 2005, Clinical Cancer Research.

[4]  P. Gunning,et al.  Identification of homo- and heteromeric interactions between members of the breast carcinoma-associated D52 protein family using the yeast two-hybrid system , 1998, Oncogene.

[5]  G. Sherlock,et al.  The prognostic role of a gene signature from tumorigenic breast-cancer cells. , 2007, The New England journal of medicine.

[6]  S. Paik,et al.  Technology Insight: application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer , 2005, Nature Clinical Practice Oncology.

[7]  Tian-Li Wang,et al.  Notch3 gene amplification in ovarian cancer. , 2006, Cancer research.

[8]  Margaret Gardiner-Garden,et al.  Overexpression of the Cell Adhesion Molecules DDR1, Claudin 3, and Ep-CAM in Metaplastic Ovarian Epithelium and Ovarian Cancer , 2004, Clinical Cancer Research.

[9]  Alberto Riva,et al.  Defining aggressive prostate cancer using a 12-gene model. , 2006, Neoplasia.

[10]  S. Pileri,et al.  Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI. , 2005, Blood.

[11]  Borja Saez,et al.  Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma. , 2006, Haematologica.

[12]  Ning Weng,et al.  Identification of Annexin VI as a Ca2+-sensitive CRHSP-28-binding Protein in Pancreatic Acinar Cells* , 2002, The Journal of Biological Chemistry.

[13]  I. Bièche,et al.  Identification of a three-gene expression signature of poor-prognosis breast carcinoma , 2004, Molecular Cancer.

[14]  S. Dhanasekaran,et al.  Integrative analysis of genomic aberrations associated with prostate cancer progression. , 2007, Cancer research.

[15]  David I. Smith,et al.  Induction of Tumorigenesis and Metastasis by the Murine Orthologue of Tumor Protein D52 , 2007, Molecular Cancer Research.

[16]  P. Nelson,et al.  PrLZ, a Novel Prostate-Specific and Androgen-Responsive Gene of the TPD52 Family, Amplified in Chromosome 8q21.1 and Overexpressed in Human Prostate Cancer , 2004, Cancer Research.

[17]  P. Gunning,et al.  The 3′-end of the human β-actin gene enhances activity of the β-actin expression vector system: construction of improved vectors , 1997 .

[18]  C. Clarke,et al.  The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma , 2000, Genes, chromosomes & cancer.

[19]  N. Kohl,et al.  Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival. , 2007, Cancer research.

[20]  Zuo-min Zhou,et al.  A testis-specific and testis developmentally regulated tumor protein D52 (TPD52)-like protein TPD52L3/hD55 interacts with TPD52 family proteins. , 2006, Biochemical and biophysical research communications.

[21]  C. Collins,et al.  High‐resolution array comparative genomic hybridization of chromosome arm 8q: Evaluation of genetic progression markers for prostate cancer , 2005, Genes, chromosomes & cancer.

[22]  S. H. Wilson,et al.  Alternative splicing as a mechanism for regulating 14-3-3 binding: interactions between hD53 (TPD52L1) and 14-3-3 proteins. , 2003, Journal of molecular biology.

[23]  D. Allred,et al.  Development of Standard Estrogen and Progesterone Receptor Immunohistochemical Assays for Selection of Patients for Antihormonal Therapy , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[24]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[25]  K. Byth,et al.  Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer , 2005, International journal of cancer.

[26]  L. Chung,et al.  PC-1/PrLZ contributes to malignant progression in prostate cancer. , 2007, Cancer research.

[27]  M. K. Byeon,et al.  Characterization of human N8 protein , 1997, Oncogene.

[28]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Jorma Isola,et al.  Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. , 2003, Cancer research.

[30]  Wonshik Han,et al.  Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer , 2006, BMC Cancer.

[31]  W. Sellers,et al.  Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer , 2004, Cancer Research.

[32]  Steven Ma,et al.  Principal Component Analysis in Linear Regression Survival Model with Microarray Data , 2021, Journal of Data Science.

[33]  C. Sotiriou,et al.  Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? , 2007, Nature Reviews Cancer.

[34]  Peter W. Andrews,et al.  Novel Genomic Aberrations in Testicular Germ Cell Tumors by Array-CGH, and Associated Gene Expression Changes , 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[35]  Johan Staaf,et al.  High‐resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization , 2007, Genes, chromosomes & cancer.

[36]  J. Pollack,et al.  RNA interference‐based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes , 2006, Genes, chromosomes & cancer.

[37]  S. Hirohashi,et al.  Genome‐wide array‐based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome , 2007, Cancer science.

[38]  Kenny Q. Ye,et al.  Novel patterns of genome rearrangement and their association with survival in breast cancer. , 2006, Genome research.

[39]  Jennifer A Byrne,et al.  The tumor protein D52 family: many pieces, many puzzles. , 2004, Biochemical and biophysical research communications.

[40]  A. Dutra,et al.  Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer , 2007, Genes, chromosomes & cancer.

[41]  Jennifer A Byrne,et al.  D53 (TPD52L1) is a cell cycle-regulated protein maximally expressed at the G2-M transition in breast cancer cells. , 2005, Experimental cell research.

[42]  C. Nourse,et al.  Identification of MAL2, a novel member of the mal proteolipid family, though interactions with TPD52-like proteins in the yeast two-hybrid system. , 2001, Genomics.